Summary:
A randomised, double blind, placebo-controlled trial of disjunctive BHV-4157 in Obsessive Compulsive Disorder
Criteria:- Primary diagnosis of obsessive-compulsive disorder (OCD) as per Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition as confirmed by the MINI at Screening; The duration of the subject's illness must be ≥ 1 year;
- Subjects must be currently experiencing non-response or inadequate response to their current Standard of Care (SOC) medication
Subjects must be on stable doses of other psychotropic medication (with exclusions specified below) for at least 12 weeks prior to screening
Qualified Participants May Receive:
Free medication, and $75.00 per every completed visit; there are 6 visits total